JC Agwu
Fri 15 12:54
OC4.5
Oral Communications 4
Peer Review: A tool to improve Paediatric Diabetes services
R Amin
Fri 15 09:30
S3.2
Symposium 3 - Present and future: novelty and goals
Complications of Type 1 Diabetes - Current dilemmas
R Anderson
Thu 14 11:30
S1.2
Symposium 1 – care and controversies: present and future
Preservation of fertility
T Barrett
Fri 15 11:40
OC3.2
Oral Communications 3
GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort
J Blair
Thu 14 14:54
OC2.10
Oral Communications 2
A new approach to the definition and diagnosis of adrenal insufficiency during inhaled corticosteroid therapy for asthma
F Campbell
Leeds, UK
Fri 15 09:00
S3.1
Symposium 3 - Present and future: novelty and goals
Benefits of diabetes networks and beyond
Leeds, UK
Fri 15 14:45
S4.1
Symposium 4 - Debate: Pump Vs MDI in all children with T1DM
Pump therapy in all newly diagnosed T1DM
Leeds, UK
JC Carel
Paris, France
Wed 13 16:45
Industry Sponsored Satellite Symposium - Updates on Turner Syndrome and Prader-Willi Syndrome
Turner syndrome: what can we do better?
Paris, France
Thu 14 12:00
S1.3
Symposium 1 – care and controversies: present and future
SAGhe: GH safety and long term concerns
Paris, France
E Carolan
Dublin, Ireland
Fri 15 12:10
OC3.5
Oral Communications 3
Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity – is obesity increasing the future risk of cancer in children?
Dublin, Ireland
L Chan
Thu 14 14:00
OC2.1
Oral Communications 2
Whole Exome Sequencing as a diagnostic tool in adrenal insufficiency
M Cheung
Thu 14 14:24
OC2.5
Oral Communications 2
Continuous Subcutaneous Infusion of Parathyroid Hormone reduces PTH requirement in patient with activating mutation of the calcium sensing receptor
A Deeb
Abu Dhabi, UAE
Fri 15 12:48
OC4.4
Oral Communications 4
Special Features of Neonatal Diabetes in a Series of Arab Patients from the Gulf Region
Abu Dhabi, UAE
R Dias
Thu 14 14:30
OC2.6
Oral Communications 2
Review of the clinical scoring systems in Silver-Russell syndrome and development of modified diagnostic criteria to guide molecular genetic testing
C Frerichs
Fri 15 12:42
OC4.3
Oral Communications 4
The Incentive Trial: Do financial rewards improve glycaemic control in teenagers with poorly controlled Type 1 Diabetes?
C Gaston-Massuet
Thu 14 10:10
OC1.8
Oral Communications 1
The repressor activity of the Wnt/β-Catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development
E Gevers
Fri 15 11:00
BSPED 2011 Research Award Winners Presentation
Does SOX2 regulate bone stem / progenitor cells?
H Gleeson
Fri 15 08:25
Industry Sponsored Satellite Symposium - Optimising endocrine care in the Hypopituitary Patient
Growing up with Growth Hormone Deficiency – indicators and measures of successful endocrine care
L Gregory
Thu 14 14:36
OC2.7
Oral Communications 2
Novel lethal form of hypopituitarism associated with the first recessive LHX4 mutation
L Guasti
Thu 14 14:18
OC2.4
Oral Communications 2
FGF21 causes GH resistance in human chondrocytes through activation of SOCS2 and inhibition of IGF1 expression
A Hokken-Koelega
Rotterdam, The Netherlands
Wed 13 17:30
Industry Sponsored Satellite Symposium - Updates on Turner Syndrome and Prader-Willi Syndrome
Prader-Willi Syndrome: update on MDT management of children with Prader-Wili Syndrome
Rotterdam, The Netherlands
S Howard
Thu 14 09:40
OC1.5
Oral Communications 1
Novel Genes Affecting the Timing of Puberty
C Hughes
Thu 14 14:12
OC2.3
Oral Communications 2
Clinical phenotype of patients with MCM4 mutation suggests pubertal delay in males
T Hulse
Fri 15 15:15
S4.2
Symposium 4 - Debate: Pump Vs MDI in all children with T1DM
MDI in all newly diagnosed T1DM
Z Juma
Thu 14 09:00
OC1.1
Oral Communications 1
Growth Hormone (GH) testing – Reducing the need for a second test for the diagnosis of Growth Hormone deficiency
S Khare
Fri 15 12:30
OC4.1
Oral Communications 4
Risk factors for emergency hospital admission for diabetic ketoacidosis in children and young people: national cross-sectional analysis
R Knowles
Thu 14 16:00
S2.2
Symposium 2 - Recent advances in CAH management
Paediatric surveillance for CAH – informing newborn screening policy
J Kowalczyk
Thu 14 10:20
OC1.9
Oral Communications 1
Genetic characterisation of short children with potential defects of GH action by single gene sequencing
A Kyriakou
Glasgow, UK
Thu 14 09:20
OC1.3
Oral Communications 1
The Utility Of AMH For Predicting Testosterone Response To HCG Stimulation In Children With Suspected DSD
Glasgow, UK
A Leiper
Thu 14 11:00
S1.1
Symposium 1 – care and controversies: present and future
Gonadal Function and Fertility after Cancer Treatment in Childhood
J Ludvigsson
Linköping, Sweden
Fri 15 14:00 -14:45
PL1
Plenary Guest Lecture
Early intervention on type 1 diabetes
Linköping, Sweden
R Moon
Southampton, UK
Thu 14 14:06
OC2.2
Oral Communications 2
Increased bone area without reduction in volumetric bone mineral density in children treated with glucocorticoids for nephrotic syndrome
Southampton, UK
R Prasad
Thu 14 10:00
OC1.7
Oral Communications 1
A mutation in thioredoxin reductase 2 (TXNRD2) is associated with familial glucocorticoid deficiency (FGD)
T Randell
Fri 15 10:00
S3.3
Symposium 3 - Present and future: novelty and goals
What are the barriers of implementation to BPT
R Ross
Thu 14 15:30
S2.1
Symposium 2 - Recent advances in CAH management
CaHASE – A UK collaborative study on CAH in adults
P Sachdev
Fri 15 12:20
OC3.6
Oral Communications 3
A feasibility study of intra-gastric balloons (supported by a lifestyle programme) for the treatment of severe adolescent obesity - the (BOB) Study
N Schoenmakers
Thu 14 14:48
OC2.9
Oral Communications 2
A comprehensive next generation sequencing-based strategy for genetic diagnosis in congenital hypothyroidism (CH)
S Senniappan
Fri 15 11:50
OC3.3
Oral Communications 3
Successful Treatment of Four Patients with Severe Hyperinsulinaemic Hypoglycaemia with a novel therapy using mTOR Inhibitor
P Shah
Fri 15 12:00
OC3.4
Oral Communications 3
Successful Use of Long Acting Octreotide in Treatment of Congenital Hyperinsulinism
S Shalet
Fri 15 08:05
Industry Sponsored Satellite Symposium - Optimising endocrine care in the Hypopituitary Patient
Thyroxine and Hydrocortisone Replacement
S Shepherd
Thu 14 14:42
OC2.8
Oral Communications 2
Establishing a national audit of paediatric GH prescribing
A Sinha
Fri 15 11:10
BSPED 2011 Research Award Winners Presentation
Understanding the role of Vitamin D in skeletal muscle function using
E Sirka
Fri 15 13:00
OC4.6
Oral Communications 4
Increased urinary Megalin and Cubulin excretion in children with Type 1 Diabetes Mellitus (T1DM) - an association with low molecular weight protein loss
R Srinivasan
Thu 14 09:50
OC1.6
Oral Communications 1
Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne Muscular Dystrophy
H Storr
Fri 15 11:20
BSPED 2011 Research Award Winners Presentation
Interplay of the fetal adrenal cortex, placental corticotrophin-releasing hormone
A Subbarayan
Fri 15 12:36
OC4.2
Oral Communications 4
Maturity-onset diabetes of Young 5 (MODY5) with Gallbladder duplication cyst: a novel case
C Wei
Bristol, UK
Thu 14 09:30
OC1.4
Oral Communications 1
Abnormal glucose homeostasis in survivors of Childhood Acute Lymphoblastic Leukaemia (ALL) treated with Bone Marrow Transplantation (BMT) and Total Body Irradiation (TBI) is associated with reduced Beta-cell reserve and pancreatic volume
Bristol, UK
C Wood
Fri 15 11:30
OC3.1
Oral Communications 3
Catch up growth and insulin sensitivity in adolescent children born preterm
G Woods
Thu 14 09:10
OC1.2
Oral Communications 1
A single centre audit of the 2012 UK Newborn Screening Programme Guidelines for pre-term infants
Wed 13 09:30
Registration
Registration
Wed 13 16:45
Industry Sponsored Satellite Symposium - Updates on Turner Syndrome and Prader-Willi Syndrome
Turner syndrome: what can we do better?
Paris, France
Wed 13 17:30
Industry Sponsored Satellite Symposium - Updates on Turner Syndrome and Prader-Willi Syndrome
Prader-Willi Syndrome: update on MDT management of children with Prader-Wili Syndrome
Rotterdam, The Netherlands
Wed 13 18:15
Welcome Reception
Thu 14 08:00
Registration
Registration
Thu 14 08:30
Welcome and Lighting of the Lamp
J Cohen (Brighton)
Thu 14 09:00
OC1.1
Oral Communications 1
Growth Hormone (GH) testing – Reducing the need for a second test for the diagnosis of Growth Hormone deficiency
Thu 14 09:10
OC1.2
Oral Communications 1
A single centre audit of the 2012 UK Newborn Screening Programme Guidelines for pre-term infants
Thu 14 09:20
OC1.3
Oral Communications 1
The Utility Of AMH For Predicting Testosterone Response To HCG Stimulation In Children With Suspected DSD
Glasgow, UK
Thu 14 09:30
OC1.4
Oral Communications 1
Abnormal glucose homeostasis in survivors of Childhood Acute Lymphoblastic Leukaemia (ALL) treated with Bone Marrow Transplantation (BMT) and Total Body Irradiation (TBI) is associated with reduced Beta-cell reserve and pancreatic volume
Bristol, UK
Thu 14 09:40
OC1.5
Oral Communications 1
Novel Genes Affecting the Timing of Puberty
Thu 14 09:50
OC1.6
Oral Communications 1
Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne Muscular Dystrophy
Thu 14 10:00
OC1.7
Oral Communications 1
A mutation in thioredoxin reductase 2 (TXNRD2) is associated with familial glucocorticoid deficiency (FGD)
Thu 14 10:10
OC1.8
Oral Communications 1
The repressor activity of the Wnt/β-Catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development
Thu 14 10:20
OC1.9
Oral Communications 1
Genetic characterisation of short children with potential defects of GH action by single gene sequencing
Thu 14 10:30
Tea & Coffee
Thu 14 11:00
S1.1
Symposium 1 – care and controversies: present and future
Gonadal Function and Fertility after Cancer Treatment in Childhood
Thu 14 11:30
S1.2
Symposium 1 – care and controversies: present and future
Preservation of fertility
Thu 14 12:00
S1.3
Symposium 1 – care and controversies: present and future
SAGhe: GH safety and long term concerns
Paris, France
Thu 14 12:30
Lunch
Thu 14 13:15
Poster Tour
Thu 14 14:00
OC2.1
Oral Communications 2
Whole Exome Sequencing as a diagnostic tool in adrenal insufficiency
Thu 14 14:06
OC2.2
Oral Communications 2
Increased bone area without reduction in volumetric bone mineral density in children treated with glucocorticoids for nephrotic syndrome
Southampton, UK
Thu 14 14:12
OC2.3
Oral Communications 2
Clinical phenotype of patients with MCM4 mutation suggests pubertal delay in males
Thu 14 14:18
OC2.4
Oral Communications 2
FGF21 causes GH resistance in human chondrocytes through activation of SOCS2 and inhibition of IGF1 expression
Thu 14 14:24
OC2.5
Oral Communications 2
Continuous Subcutaneous Infusion of Parathyroid Hormone reduces PTH requirement in patient with activating mutation of the calcium sensing receptor
Thu 14 14:30
OC2.6
Oral Communications 2
Review of the clinical scoring systems in Silver-Russell syndrome and development of modified diagnostic criteria to guide molecular genetic testing
Thu 14 14:36
OC2.7
Oral Communications 2
Novel lethal form of hypopituitarism associated with the first recessive LHX4 mutation
Thu 14 14:42
OC2.8
Oral Communications 2
Establishing a national audit of paediatric GH prescribing
Thu 14 14:48
OC2.9
Oral Communications 2
A comprehensive next generation sequencing-based strategy for genetic diagnosis in congenital hypothyroidism (CH)
Thu 14 14:54
OC2.10
Oral Communications 2
A new approach to the definition and diagnosis of adrenal insufficiency during inhaled corticosteroid therapy for asthma
Thu 14 15:00
Tea & Coffee
Thu 14 15:30
S2.1
Symposium 2 - Recent advances in CAH management
CaHASE – A UK collaborative study on CAH in adults
Thu 14 16:00
S2.2
Symposium 2 - Recent advances in CAH management
Paediatric surveillance for CAH – informing newborn screening policy
Thu 14 16:45
BSPED Annual General Meeting
Thu 14 19:00
Pre-Dinner Welcome Reception
Thu 14 19:30
Conference Dinner
Fri 15 08:00
Registration
Registration
Fri 15 09:00
S3.1
Symposium 3 - Present and future: novelty and goals
Benefits of diabetes networks and beyond
Leeds, UK
Fri 15 09:30
S3.2
Symposium 3 - Present and future: novelty and goals
Complications of Type 1 Diabetes - Current dilemmas
Fri 15 10:00
S3.3
Symposium 3 - Present and future: novelty and goals
What are the barriers of implementation to BPT
Fri 15 10:30
Tea & Coffee
Fri 15 11:00
BSPED 2011 Research Award Winners Presentation
Does SOX2 regulate bone stem / progenitor cells?
Fri 15 11:10
BSPED 2011 Research Award Winners Presentation
Understanding the role of Vitamin D in skeletal muscle function using
Fri 15 11:20
BSPED 2011 Research Award Winners Presentation
Interplay of the fetal adrenal cortex, placental corticotrophin-releasing hormone
Fri 15 11:30
OC3.1
Oral Communications 3
Catch up growth and insulin sensitivity in adolescent children born preterm
Fri 15 11:40
OC3.2
Oral Communications 3
GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort
Fri 15 11:50
OC3.3
Oral Communications 3
Successful Treatment of Four Patients with Severe Hyperinsulinaemic Hypoglycaemia with a novel therapy using mTOR Inhibitor
Fri 15 12:00
OC3.4
Oral Communications 3
Successful Use of Long Acting Octreotide in Treatment of Congenital Hyperinsulinism
Fri 15 12:10
OC3.5
Oral Communications 3
Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity – is obesity increasing the future risk of cancer in children?
Dublin, Ireland
Fri 15 12:20
OC3.6
Oral Communications 3
A feasibility study of intra-gastric balloons (supported by a lifestyle programme) for the treatment of severe adolescent obesity - the (BOB) Study
Fri 15 12:30
OC4.1
Oral Communications 4
Risk factors for emergency hospital admission for diabetic ketoacidosis in children and young people: national cross-sectional analysis
Fri 15 12:36
OC4.2
Oral Communications 4
Maturity-onset diabetes of Young 5 (MODY5) with Gallbladder duplication cyst: a novel case
Fri 15 12:42
OC4.3
Oral Communications 4
The Incentive Trial: Do financial rewards improve glycaemic control in teenagers with poorly controlled Type 1 Diabetes?
Fri 15 12:48
OC4.4
Oral Communications 4
Special Features of Neonatal Diabetes in a Series of Arab Patients from the Gulf Region
Abu Dhabi, UAE
Fri 15 12:54
OC4.5
Oral Communications 4
Peer Review: A tool to improve Paediatric Diabetes services
Fri 15 13:00
OC4.6
Oral Communications 4
Increased urinary Megalin and Cubulin excretion in children with Type 1 Diabetes Mellitus (T1DM) - an association with low molecular weight protein loss
Fri 15 13:06
Lunch
Fri 15 14:00 -14:45
PL1
Plenary Guest Lecture
Early intervention on type 1 diabetes
Linköping, Sweden
Fri 15 14:45
S4.1
Symposium 4 - Debate: Pump Vs MDI in all children with T1DM
Pump therapy in all newly diagnosed T1DM
Leeds, UK
Fri 15 15:15
S4.2
Symposium 4 - Debate: Pump Vs MDI in all children with T1DM
MDI in all newly diagnosed T1DM
Fri 15 15:45
Close of meeting

0 result(s) found.